Back
MainStay MacKay DefinedTerm Municipal Opportunities Fund Vs. NovoCure Industry Stock Comparison
Sell
16
MMD
MainStay MacKay DefinedTerm Municipal Opportunities Fund
Last Price:
15.58
Seasonality Move:
2.11%
Buy
75
NVCR
NovoCure
Last Price:
33.40
Seasonality Move:
-5.24%
Sell
16
MainStay MacKay DefinedTerm Municipal Opportunities Fund (MMD)
is a Sell
Is MainStay MacKay DefinedTerm Municipal Opportunities Fund a Buy, Sell or Hold?
- The current MainStay MacKay DefinedTerm Municipal Opportunities Fund [MMD] share price is $15.59. The Score for MMD is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- MMD is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
75
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MMD Stock Price Chart
What is MainStay MacKay DefinedTerm Municipal Opportunities Fund's stock price today?
-
The MainStay MacKay DefinedTerm Municipal Opportunities Fund share price today is $15.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MMD is experiencing slight selling pressure.
MMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 35.22 | Sell |
| Chaikin Money Flow: | -8145 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.72 - 16.44) | Sell |
| Bollinger Bands (100): | (16.23 - 16.93) | Sell |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.78 | Buy |
| Relative Strength Index (14 RSI): | 75.34 | Buy |
| Chaikin Money Flow: | 1118573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.36 - 28.56) | Buy |
| Bollinger Bands (100): | (14.7 - 22.78) | Buy |
MMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.86 | Sell |
| 20-day SMA: | 15.93 | Sell |
| 50-day SMA: | 16.39 | Sell |
| 200-day SMA: | 16.46 | Sell |
| 8-day EMA: | 15.8 | Sell |
| 20-day EMA: | 15.98 | Sell |
| 50-day EMA: | 16.26 | Sell |
| 200-day EMA: | 16.45 | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.6 | Buy |
| 20-day SMA: | 23.68 | Buy |
| 50-day SMA: | 19.33 | Buy |
| 200-day SMA: | 17.9 | Buy |
| 8-day EMA: | 29.53 | Buy |
| 20-day EMA: | 25.45 | Buy |
| 50-day EMA: | 21.38 | Buy |
| 200-day EMA: | 19.88 | Buy |
MainStay MacKay DefinedTerm Municipal Opportunities Fund Earnings Growth & MMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
MainStay MacKay DefinedTerm Municipal Opportunities Fund Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||